Published in
Esmo Open, Esmo Open, 2(7), p. 100422, 2022
DOI: 10.1016/j.esmoop.2022.100422
Links
Tools
Phase II study of cabazitaxel as second-third line treatment in patients with metastatic adrenocortical carcinoma
Journal article published in 2022 by
M. Laganà,
S. Grisanti,
R. Ambrosini,
D. Cosentini,
A. Abate 
,
M. Zamparini,
V. D. Ferrari,
A. Gianoncelli,
A. Turla,
L. Canu,
M. Terzolo,
G. A. M. Tiberio,
S. Sigala,
A. Berruti
,
M. Zamparini,
V. D. Ferrari,
A. Gianoncelli,
A. Turla,
L. Canu,
M. Terzolo,
G. A. M. Tiberio,
S. Sigala,
A. Berruti
This paper was not found in any repository; the policy of its publisher is unknown or unclear.
Full text: Unavailable
Data provided by 